DNazyme-mediated cleavage of Twist transcripts and increase in cellular apoptosis

Biochemical and Biophysical Research Communications

Volumn 300, Issue 1, 2003, Pages 178-181

  Hjiantoniou, Eleni ^a   Iseki, Sachiko ^b   Uney, James B ^c   Phylactou, Leonidas A ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Apoptosis; Basic helix loop helix; DNazyme; Twist

Indexed keywords

BASE; DNA; DNAZYME; HELIX LOOP HELIX PROTEIN; MESSENGER RNA; NUCLEIC ACID; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATALYSIS; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; DOWN REGULATION; GENETIC TRANSCRIPTION; MOLECULE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKULL DEVELOPMENT;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, CATALYTIC; DOWN-REGULATION; MICE; NUCLEAR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TWIST TRANSCRIPTION FACTOR; UP-REGULATION;

ANIMALIA;

EID: 0037227782     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02804-8     Document Type: Article

References (24)

1. J.B. Opalinska, A.M. Gewirtz, Nucleic-acid therapeutics: Basic principles and recent applications, Nat. Rev. Drug Discov. 1 (2002) 503-514.
2. M. Sioud, Nucleic acid enzymes as a novel generation of anti-gene agents, Curr. Mol. Med. 1 (2001) 575-588.
3. L.A. Phylactou, M.W. Kilpatrick, M.J.A. Wood, Ribozymes as therapeutic tools for genetic disease, Hum. Mol. Genet. 7 (1998) 1649-1653.
4. L.A. Phylactou, Ribozyme and peptide-nucleic acid-based gene therapy, Adv. Drug Deliv. Rev. 44 (2000) 97-108.
5. G.M. Emilsson, R.R. Breaker, Deoxyribozymes: New activities and new applications, Cell. Mol. Life Sci. 59 (2002) 596-607.
6. S.W. Santoro, G.F. Joyce, A general purpose RNA-cleaving DNA enzyme, Proc. Natl. Acad. Sci. USA 94 (1997) 4262-4266.
7. L.Q. Sun, M.J. Cairns, W.L. Gerlach, C. Witherington, L. Wang, A. King, Suppression of smooth muscle cell proliferation by a c-myc RNA-cleaving deoxyribozyme, J. Biol. Chem. 274 (1999) 17236-17241.
8. X. Zhang, Y. Xu, H. Ling, T. Hattori, Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme, FEBS Lett. 458 (1999) 151-156.
9. L. Zhang, W.J. Gasper, S.A. Stass, O.B. Ioffe, M.A. Davis, A.J. Mixson, Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2, Cancer Res. 62 (2002) 5463-5469.
10. B. Thisse, C. Stoetzel, C. Gorostiza-Thisse, F. Perrin-Schmitt, Sequence of the Twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos, EMBO J. 7 (1988) 2175-2183.
11. E.N. Olson, W.H. Klein, bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out, Genes Dev. 8 (1994) 1-8.
12. T. Kadesch, Consequences of heteromeric interactions among helix-loop-helix proteins, Cell Growth Differ. 4 (1993) 49-55.
13. M. Hebrok, K. Wertz, E.M. Fuchtbauer, M-Twist is an inhibitor of muscle differentiation, Dev. Biol. 165 (1994) 537-544.
14. D.B. Spicer, J. Rhee, W.L. Cheung, A.B. Lassar, Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist, Science 272 (1996) 1476-1480.
15. M.S. Lee, G.N. Lowe, D.D. Strong, J.E. Wergedal, C.A. Glackin, TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage, J. Cell. Biochem. 75 (1999) 566-577.
16. S.S. Murray, C.A. Glackin, K.A. Winters, D. Gazit, A.J. Kahn, E.J. Murray, Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells, J. Bone Miner. Res. 7 (1992) 1131-1138.
17. D.P. Rice et al., Integration of FGF and TWIST in calvarial bone and suture development, Development 127 (2000) 1845-1855.
18. V. el Ghouzzi et al., Mutations of the TWIST gene in the Saethre-Chotzen syndrome, Nat. Genet. 15 (1997) 42-46.
19. T.D. Howard et al., Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome, Nat. Genet. 15 (1997) 36-41.
20. D. Johnson, S. Iseki, A.O. Wilkie, G.M. Morriss-Kay, Expression patterns of Twist and Fgfr1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis, Mech. Dev. 91 (2000) 341-345.
21. J. Dupont, A.M. Fernandez, C.A. Glackin, L. Helman, D. LeRoith, Insulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the anti-apoptotic effects of the IGF-1 receptor, J. Biol. Chem. 276 (2001) 26699-26707.
22. R. Maestro et al., Twist is a potential oncogene that inhibits apoptosis, Genes Dev. 13 (1999) 2207-2217.
23. N. Funato, K. Ohtani, K. Ohyama, T. Kuroda, M. Nakamura, Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors, Mol. Cell. Biol. 21 (2001) 7416-7428.
24. Y. Hamamori, H.Y. Wu, V. Sartorelli, L. Kedes, The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist, Mol. Cell. Biol. 17 (1997) 6563-6573.